Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSkye Bioscience Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.38 | -$0.21 | -$0.31 |
| Q2 2026 | 4 | -$0.30 | -$0.13 | -$0.24 |
| Q3 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 2 | -$0.23 | -$0.23 | -$0.23 |
| Q1 2027 | 2 | -$0.25 | -$0.25 | -$0.25 |
| Q2 2027 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q3 2027 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2027 | 2 | -$0.30 | -$0.30 | -$0.30 |
| Q1 2028 | 3 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2028 | 2 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2028 | 2 | -$0.36 | -$0.36 | -$0.36 |
| Q4 2028 | 3 | -$0.38 | -$0.38 | -$0.38 |
Skye Bioscience Inc Earnings Date And Information
Skye Bioscience Inc last posted its earnings results on Tuesday, March 10th, 2026. The company reported $-0.36 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2971 by $0.0629. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Skye Bioscience Inc has generated $-1 earnings per share over the last year ($-1.41 diluted earnings per share) and currently has a price-to-earnings ratio of -0.59. Skye Bioscience Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Skye Bioscience Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 2025 | -$0.30 | -$0.36 | -0.06 | $0 | $0 |
| 11/10/2025 | Q3 2025 | -$0.33 | -$0.32 | 0.01 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$0.34 | -$0.44 | -0.1 | N/A | $0 |
| 05/08/2025 | Q1 2025 | -$0.31 | -$0.28 | 0.03 | N/A | $0 |
| 03/20/2025 | Q4 2024 | -$0.28 | -$0.24 | 0.04 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.26 | -$0.10 | 0.16 | N/A | $0 |
| 08/09/2024 | Q2 2024 | -$0.20 | -$0.20 | 0 | N/A | $0 |
| 05/10/2024 | Q1 2024 | -$0.16 | -$0.18 | -0.02 | N/A | $0 |
| 03/21/2024 | Q4 2023 | -$0.38 | -$0.36 | 0.02 | N/A | $0 |
| 11/13/2023 | Q3 2023 | N/A | -$3.17 | N/A | N/A | $0 |
| 08/07/2023 | Q2 2023 | N/A | -$0.80 | N/A | N/A | $0 |
| 05/11/2023 | Q1 2023 | N/A | -$1.37 | N/A | N/A | $0 |
| 03/31/2023 | Q4 2022 | N/A | -$4.99 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$1.58 | N/A | N/A | $0 |
| 08/15/2022 | Q2 2022 | N/A | -$2.50 | N/A | N/A | $0 |
| 05/06/2022 | Q1 2022 | N/A | -$2.50 | N/A | N/A | $0 |
| 03/25/2022 | Q4 2021 | N/A | -$1.53 | N/A | N/A | $0 |
| 11/10/2021 | Q3 2021 | N/A | -$1.10 | N/A | N/A | $0 |
| 08/05/2021 | Q2 2021 | N/A | -$2.50 | N/A | N/A | $0 |
| 05/07/2021 | Q1 2021 | N/A | -$2.50 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Skye Bioscience Inc Earnings: FAQ's
The conference call for Skye Bioscience Inc's latest earnings report can be listened to online.
The conference call transcript for Skye Bioscience Inc's latest earnings report can be read online.
Skye Bioscience Inc (:SKYE) has a recorded net income of $-55,924,814.Skye Bioscience Inc has generated $-1.41 earnings per share over the last four quarters.
Skye Bioscience Inc (:SKYE) has a price-to-earnings ratio of -0.59 and price/earnings-to-growth ratio is 0.01.